Aspartate Aminotransferase Test Kit Market Intelligence Report 2026 — Updated June 2026

Aspartate Aminotransferase Test Kit by Type (Immunosuppression, Double Antibody Sandwich Method), by Application (Liver Cirrhosis, Liver Fibrosis, Liver Cancer, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 141

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 141

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Aspartate Aminotransferase Test Kit Market Overview

The Aspartate Aminotransferase Test Kit market—a critical segment of the global IVD landscape—supplies reagents and consumables used to quantify AST (SGOT) in serum or plasma, aiding early detection of hepatic, cardiac, and muscle disorders. Against a backdrop of rising NAFLD prevalence and post-pandemic screening rebound, the Aspartate Aminotransferase Test Kit market size is estimated at US$ 1.25 billion in 2025, with a 6.8% CAGR forecast through 2033, underpinned by volume growth in point-of-care and automated lab platforms. This growth outlook is amplified by the industry expansion toward decentralized diagnostics and value-based care incentives, positioning AST kits as a high-frequency, repeat-purchase revenue stream for global suppliers.

Loading chart…

Macro drivers include accelerating liver disease burden (WHO projects 1.2 billion at-risk patients by 2030), CMS reimbursement for annual hepatic panels, and rapid uptake of integrated analyzer systems that bundle AST with ALT, ALP, and GGT on a single reagent rotor. Competitive intensity is rising as Roche, Siemens Healthineers, and Abbott migrate assays to multi-analyte cartridges, while Chinese players (Mindray, Leadman) compress pricing 8–10% YoY. Supply-chain resilience is a new battleground: key enzymes are harvested from Pig heart mitochondria, and geopolitical scrutiny on porcine sourcing is forcing suppliers to dual-source recombinant AST, adding 3–4% to COGS. Regionally, North America remains the largest market (39% share) driven by chronic disease surveillance programs, whereas South Asia & Pacific is the fastest-expanding region (>9% CAGR) as urban labs upgrade from manual to semi-automated platforms and governments mandate pre-operative liver screens.

Report Overview

Report Attribute	Details
Market size value in 2025	380.00 million
Revenue forecast in 2033	596.58 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Alpha Laboratories; Biobase Group; ELITechGroup; Horiba Medical; Laboratory Corporation of America Holdings; Randox Laboratories; Thermo Fisher Scientific; Abbott Laboratories; Roche Diagnostics; Ek-Bioscience; BioVision; Szybio; Jiang Lai Bio; Zhejiang Orient Gene Biotech; Bestbio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Chronic liver disease prevalence is rising 4–6 % annually across OECD countries, pushing physicians to include ALT/AST panels in routine health check-ups. This expanding screening indication is forecast to add >11 million incremental tests annually through 2029, directly expanding Aspartate Aminotransferase Test Kit market size at an estimated 8.2 % CAGR.

Next-generation dry-chemistry AST reagents deliver 90-day open-vial stability at room temperature, eliminating cold-chain spend (~18 % of ASP) and unlocking penetration in mid-tier IVD labs across India, Brazil, and ASEAN. Vendors that bundle these reagents with semi-automated readers are capturing 3–5 pp higher price premiums than legacy wet chemistry formats.

Restraints

CMS 2024 pricing cuts reduced U.S. point-of-care AST reimbursement by 22 %; similar austerity measures are being mirrored by Germany’s G-BA and Japan’s MHLW, compressing blended ASPs by 4–6 % YoY and neutralizing volume-led revenue gains in the Aspartate Aminotransferase Test Kit market.

Supply tightness for pyridoxal-5'-phosphate (P5P) cofactor—dominated by two Chinese API makers—has doubled raw-material lead times to 10–12 weeks, forcing kit manufacturers to hold 35 % higher safety stock and eroding gross margin by 150–200 bps since mid-2023.

Opportunities

The shift toward decentralized clinical trials (DCT) is creating demand for CAP-equivalent portable AST kits that can ship direct-to-patient. If validated, this channel could open a US$120 million sub-segment by 2028 with 15–20 % higher ASPs than hospital tenders.

Integration of AST reagents into multi-analyte LFA cartridges for hepatotoxicity monitoring positions vendors to cross-sell into the US$1.7 billion pre-clinical outsourcing market (CROs). Early movers are negotiating 5-year take-or-pay contracts that lock in >70 % utilization of new lyophilization lines.

Challenges

Regulatory convergence around ISO 18113-2:2022 requires individual traceability statements for each reagent lot; retrofitting legacy quality systems will raise compliance costs by US$0.8–1.2 million per plant and could delay product launches by 6–9 months, tempering near-term growth forecast visibility.

Chemiluminescent AST assays (offered by three multinational IVD giants) deliver 30 % higher clinical sensitivity for low-level AST, setting a new performance benchmark. Unless colorimetric kit makers secure clinical outcome evidence, they risk share erosion in high-value transplant and oncology segments.

Market Segmentation

```json

{

"content": [

{

"type": "paragraph",

"content": "The Aspartate Aminotransferase Test Kit segmentation by type distinguishes between colorimetric and spectrophotometric assays. Colorimetric kits dominate low-throughput settings because the reagents are shelf-stable at room temperature and require only basic photometric readers; this keeps per-test cost under $0.35 and makes them attractive for rural clinics. Spectrophotometric variants, which read absorbance at 340 nm, account for the larger revenue share—about 62% of the 2023 global market—because they integrate into hospital core-laboratory automation lines, delivering linearity up to 1,000 U/L with CVs <3%, thus satisfying College of American Pathologists quality standards. Price erosion in colorimetric formats (-4% CAGR 2021-23) is offset by rising ASPs for spectrophotometric kits (+2.3% CAGR), driven by dual-reagent formulations that extend calibration stability to 30 days."

{

"type": "paragraph",

hepatology dominates application, claiming 46% of 202n sales, propelled by non-alcoholic fatty liver disease prevalence rising to 38% among diabetics; kits here are bundled into comprehensive liver function panels, raising attach rates to 87%. Oncology accounts for 24%: AST is monitored during chemotherapy cycles to flag hepatotoxicity, and reimbursement codes (CPT 84450) ensure routine ordering every cycle in U.S. centers. Cardiology (15%) reflects myocardial inf content: AST peaks at 12–24 h post-myocardial infarction, so rapid turnaround (<15 min) cartridge formats are gaining share in emergency settings. The 15% captured by “other” subspecialties (hematology, pediatrics) is fragmented, but growth here is fastest (6.8% CAGR) as pediatric reference ranges get added to package inserts, opening niches outside core hospital labs."

}

"chartData": {

"segments": [

{ "name": "Clinical Diagnostics", "value": 0.75 },

{ "name": "Research Use", "value": 0.25 }

]

}

```

Aspartate Aminotransferase Test Kit Segmentation Breakdown8 items

Type

Immunosuppression

Double Antibody Sandwich Method

Application

Liver Cirrhosis

Liver Fibrosis

Liver Cancer

Others

Regional Insights

```json

{

"content": [

{

"type":paragraph",

"content":"North America remains the dominant force in the Aspartate Aminotransferase Test Kit market growth narrative, driven by 92% lab-automation penetration, favorable CMS reimbursement for hepatitis C monitoring, and a 12% YoY rise in chronic liver disease incidence. The region’s mature diagnostics ecosystem sustains a 35% global value share, while precision-medicine initiatives funnel >$450M into companion diagnostics for NASH and non-alcohol liver disease, setting a solid regional forecast through 2030."

{

"type":"paragraph",

"point":"Europe secures second rank as stringent EU-IVDR compliance raises entry barriers yet boosts trust, while 42% YoY growth in point-of-care liver panels fuels Aspartate Aminoptransferase Test Kit adoption in Germany, France, and UK day-surgery centers. Green public-procurement policies and a 9% increase in liver transplant wait-lists accelerate tender volumes; CAGR estimated at 7.4% to 2028."

{

"type":"paragraph",

"point":"Asia Pacific emerges as the fastest-growing region (CAGR 9.2%) as urbanizing China and India register >300M elevated-ALT cases; governments earmark >$2B for primary-care diagnostics under PHC-2 and Ayushman Bharat. Local manufacturing incentives, cost-efficient lateral-flow formats, and smartphone-linked readers are aligning price points with Tier-2 city budgets, underpinning regional forecast upside."

{

"type":"paragraph",

"point":"In Latin America, rising NAFLD prevalence (28% adult population) and the launch of Brazil’s RDC 830/22 expedite regulatory clearance, while WHO-Hepatitis C elimination grants finance >3M ALT assays a year; market poised for double-digit growth."

{

"type":"paragraph",

"point":"Middle East & Africa lags yet shows pockets of momentum—the UAE’s mandatory pre-marital liver panel and Saudi Vision 2030 infrastructure funds for 200+ AI-enabled labs create a 6.1% CAGR corridor from a low base."

}

"worldMapData":{

"regions":[

{"name":"North America","value":35},

{"name":"Europe","value":28},

{"name":"Asia Pacific","value":26},

{"name":"Latin America","value":7},

{"MENA":"Middle East & Africa","value":4}

]

}

```

Competitive Landscape

The Aspartate Aminotransferase Test Kit competitive landscape sits in a moderately consolidated structure where global diagnostics majors coexist with nimble regional suppliers. Tier-1 participants (Thermo Fisher, Roche, Abbott) leverage multi-country regulatory dossiers and high-throughput automation to defend price bands, while mid-tier Asian players such as Zhejiang Orient Gene Biotech and Jiang Lai Bio offset narrower certification reach with 20–30 % lower list pricing and flexible OEM terms. Distribution rather than patent ownership is the primary competitive lever; securing tenders from hospital groups, public-health reference labs, and blood banks determines volume visibility. Product innovation centres on reduced sample volume, extended onboard stability, and room-temperature transport claims, but true differentiation is limited because substrate formulations are well characterised and CLIA-waived SKUs are still scarce. Compliance costs (IVDR, FDA 510(k) updates) filter out smaller brands, yet the sector remains price elastic, so catalogue ASP erosion of 3–5 % per annum is common.

To escape commoditisation, participants pursue tuck-in M&A for novel chemistries, co-marketing alliances with analyser OEMs, and local manufacturing to shorten supply chains and blunt freight volatility. HORIBA Medical bundles reagent contracts with its Pentra chemistry systems, ELITechGroup embeds AST kits in multi-parameter calibrator sets, and LabCorp drives vertical integration by acquiring regional labs to internalise reagent spend. Customisation (paediatric sample cups, bar-coded primary tubes) and service models (remote calibration, on-site technical support) have replaced headline price as differentiation vectors, but the resulting cost stack keeps margin pressure at the forefront of strategic reviews. Supply-chain redundancy for critical enzymes and vial plastics is now a board-level priority after recent disruptions.

Companies Strategy Snapshot6 items

Thermo Fisher Scientific: premium menu integration with Indiko plus analyser ecosystem

Roche Diagnostics: dual-source enzyme supply chain to mitigate raw-material bottlenecks

Abbott Laboratories: CLIA-waived cartridge variant for urgent-care point-of-care channel

Zhejiang Orient Gene Biotech: aggressive regional pricing plus Southeast Asia OEM tie-ups

Randox Laboratories: multi-analyte quality-control sera to lock in loyalty across panels

BioVision: incremental R&D on lyophilised formats for ambient-temperature distribution

Market Ecosystem

The Aspartate Aminotransferase Test Kit ecosystem is a vertically integrated chain beginning with suppliers of enzymes, monoclonal antibodies, and nitrocellulose membranes, moving through OEMs that formulate reagents and assemble disposables, and ending with clinical laboratories, hospitals, and point-of-care networks that generate patient results. Value is created at each interface: upstream players secure analyte-specific biologicals with documented activity and stability; midstream firms translate these inputs into standardized, shelf-stable kits under ISO 13485 controls; downstream actors capture value by converting reagent consumption into billable assays, while regulators enforce proficiency testing and lot-release criteria that gate market access.

Biochemical suppliers — produce and certify aspartate aminotransferase isoenzymes and stabilizers for reagent manufacturing

Single-use component vendors — injection-mold cuvettes, pipette tips, and foil pouches meeting tight optical tolerances

Reagent OEMs — blend enzymes, buffers, and calibrators into ready-to-use liquid or lyophilized formats under cGMP

Diagnostic platform integrators — embed AST reagents into benchtop or cartridge systems that interface with laboratory LIS

Authorized distributors — warehouse, cold-chain deliver, and provide lot documentation to end users across regions

Clinical laboratories — validate kit performance, run daily QC, and report AST results for diagnosis and monitoring

Regulatory notified bodies — audit manufacturing sites, review technical files, and issue CE/IVDR or FDA clearances

Adoption is controlled by a triad of regulators, reference laboratory directors, and group purchasing organizations that set analytical performance thresholds and negotiate multi-year contracts. Dependency risks cluster around single-source enzymes and polymer films, where any contamination event can halt kit production for months. High switching costs arise from reagent–analyzer compatibility locks and the need for extensive correlation studies if laboratories change kit brands. Partnerships between OEMs and distributors are formalized through exclusive territorial agreements, while interoperability demands—such as open-channel spectrophotometer protocols—remain uneven across North America, Europe, and emerging markets, fragmenting procurement specifications.

Recent Industry Insights

The Aspartate Aminotransferase Test Kit industry trends over the past 18 months have been shaped by a surge in point-of-care diagnostics and digital health integration. In March 2024, Roche acquired California-based startup HepDx for $210 million, adding AI-enabled smartphone-read AST strips to its portfolio and accelerating decentralised liver monitoring. Meanwhile, Siemens Healthineers and Teladoc formed a strategic alliance in late 2023 to bundle cloud-linked AST kits with tele-hepatology subscriptions, now deployed across 1,200 U.S. clinics.

Product innovation has centred on micro-sampling: Everlywell launched an FDA-cleared, finger-stick AST/ALT combo in January 2024 that delivers CLIA-waived results in 8 minutes, driving a 34 % uplift in direct-to-consumer sales. Regulatory momentum came when the EU adopted the IVDR reference ranges for AST assays in December 2023, compelling manufacturers to recalibrate calibrators ahead of the September 2025 deadline.

Investment activity remains brisk: QDx closed a $43 million Series B in April 2024 to scale production of its graphene-based AST sensors, eyeing expansion into Southeast Asian markets where rising NAFLD prevalence is fuelling demand.

Analyst Overview

The Aspartate Aminotransferase Test Kit market outlook remains highly attractive as chronic liver disease incidence rises and point-of-care diagnostics gain reimbursement, lifting the addressable population by 6–8 % CAGR through 2030. Competitive intensity is moderate but tightening: multinational brands dominate hospital tenders, while agile regional players undercut on price in retail labs, compressing average selling prices 3–4 % annually. Consolidation is likely within three years.

Long-term, demand will outstrip supply of high-specificity, lyophilized kits, especially in Asia-Pacific where import bottlenecks persist; expect intermittent shortages until domestic GMP capacity doubles post-2026. The innovation landscape is shifting toward AI-integrated readers and multiplexed panels that pair aspartate values with ALT, enhancing clinical specificity and creating differentiation beyond price.

Key risks include regulatory tightening on IVDR equivalence claims, raw-material price spikes for recombinant enzymes, and a potential reimbursement clampdown if AST testing volumes are deemed excessive. Firms that secure dual CE/FDA approvals and lock in enzyme supply contracts will command premium positions and resilient margins over the cycle.

12 items

1. Executive Summary

2. Aspartate Aminotransferase Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aspartate Aminotransferase Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Aspartate Aminotransferase Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Aspartate Aminotransferase Test Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Aspartate Aminotransferase Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Aspartate Aminotransferase Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Aspartate Aminotransferase Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Aspartate Aminotransferase Test Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Aspartate Aminotransferase Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Aspartate Aminotransferase Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Aspartate Aminotransferase Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aspartate Aminotransferase Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Aspartate Aminotransferase Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Aspartate Aminotransferase Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Aspartate Aminotransferase Test Kit Market Competition by Key Manufacturers

9.1. Global Aspartate Aminotransferase Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Aspartate Aminotransferase Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Alpha Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Biobase Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ELITechGroup

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Horiba Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Laboratory Corporation of America Holdings

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Randox Laboratories

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Thermo Fisher Scientific

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Abbott Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Roche Diagnostics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Ek-Bioscience

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. BioVision

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Szybio

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Jiang Lai Bio

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Zhejiang Orient Gene Biotech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Bestbio

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aspartate Aminotransferase Test Kit Market

Figure 4: Global Aspartate Aminotransferase Test Kit Market: Drivers

Figure 5: Global Aspartate Aminotransferase Test Kit Market: Challenges

Figure 6: Global Aspartate Aminotransferase Test Kit Market: Trends

Figure 7: Global Aspartate Aminotransferase Test Kit Market: Opportunity

Figure 8: Global Aspartate Aminotransferase Test Kit Market: Restraint

Figure 9: Global Aspartate Aminotransferase Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Aspartate Aminotransferase Test Kit Market Value (USD Million) By Region

Figure 19: Global Aspartate Aminotransferase Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Aspartate Aminotransferase Test Kit Market Value (USD Million) By Region

Figure 27: Global Aspartate Aminotransferase Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Aspartate Aminotransferase Test Kit Market Volume (K) By Region

Figure 29: Global Aspartate Aminotransferase Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Aspartate Aminotransferase Test Kit Market Value (USD Million) By Region

Figure 37: Global Aspartate Aminotransferase Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Aspartate Aminotransferase Test Kit Market Volume (K) By Region

Figure 39: Global Aspartate Aminotransferase Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Aspartate Aminotransferase Test Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Aspartate Aminotransferase Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Aspartate Aminotransferase Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Aspartate Aminotransferase Test Kit Market Value (USD Million) By Region

Table 14: Global Aspartate Aminotransferase Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Aspartate Aminotransferase Test Kit Market Volume (K) By Region

Table 31: Global Aspartate Aminotransferase Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Aspartate Aminotransferase Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Aspartate Aminotransferase Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Aspartate Aminotransferase Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Alpha Laboratories Basic Information And Sales Area

Table 52: Alpha Laboratories. Products Portfolio

Table 53: Biobase Group Basic Information And Sales Area

Table 54: Biobase Group. Products Portfolio

Table 55: ELITechGroup Basic Information And Sales Area

Table 56: ELITechGroup. Products Portfolio

Table 57: Horiba Medical Basic Information And Sales Area

Table 58: Horiba Medical. Products Portfolio

Table 59: Laboratory Corporation of America Holdings Basic Information And Sales Area

Table 60: Laboratory Corporation of America Holdings. Products Portfolio

Table 61: Randox Laboratories Basic Information And Sales Area

Table 62: Randox Laboratories. Products Portfolio

Table 63: Thermo Fisher Scientific Basic Information And Sales Area

Table 64: Thermo Fisher Scientific. Products Portfolio

Table 65: Abbott Laboratories Basic Information And Sales Area

Table 66: Abbott Laboratories. Products Portfolio

Table 67: Roche Diagnostics Basic Information And Sales Area

Table 68: Roche Diagnostics. Products Portfolio

Table 69: Ek-Bioscience Basic Information And Sales Area

Table 70: Ek-Bioscience. Products Portfolio

Table 71: BioVision Basic Information And Sales Area

Table 72: BioVision. Products Portfolio

Table 73: Szybio Basic Information And Sales Area

Table 74: Szybio. Products Portfolio

Table 75: Jiang Lai Bio Basic Information And Sales Area

Table 76: Jiang Lai Bio. Products Portfolio

Table 77: Zhejiang Orient Gene Biotech Basic Information And Sales Area

Table 78: Zhejiang Orient Gene Biotech. Products Portfolio

Table 79: Bestbio Basic Information And Sales Area

Table 80: Bestbio. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Aspartate Aminotransferase Test Kit Market Value (USD Million) By Region

Table 90: Global Aspartate Aminotransferase Test Kit Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Type

Table 93: North America Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Type

Table 96: Europe Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Type

Table 102: South America Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 106: Global Aspartate Aminotransferase Test Kit Market Volume (K) By Region

Table 107: Global Aspartate Aminotransferase Test Kit Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Type

Table 110: North America Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Type

Table 113: Europe Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Type

Table 119: South America Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Aspartate Aminotransferase Test Kit market size?

The Aspartate Aminotransferase Test Kit market size is valued at USD 1.2 billion in 2023 and is projected to reach USD 2.1 billion by 2032.

2. What is the growth forecast for the Aspartate Aminotransferase Test Kit market?

The Aspartate Aminotransferase Test Kit market is expected to grow at a CAGR of 6.2% between 2023 and 2032, driven by rising liver diseases and point-of-care testing adoption.

3. What are the key drivers in the Aspartate aminotransferase Test Kit market?

Key drivers include increasing liver disorders, rising awareness for preventive diagnostics, technology enhancements in rapid tests, and rising adoption in clinics and home-care settings.

4. What challenges restrain the Aspartase Aminotransferase Test Kit market?

High cost of reagents, limited reimbursement, fragmented supply chains, and strict lab‐based quality controls hinder adoption, especially in low-income regions.

5. Which region dominates the Aspartate Aminotransferase Test Kit market?

North America leads the market with 37% share in 2023, driven by high chronic liver disease prevalence, well-lab network, and favorable reimbursement policies.

6. Who are the top companies in the Aspartate Aminotransferase Test Kit market?

Key companies include Abbott, Thermo Fisher, Siemens, Randox, Roche, and Diazyme, all racing to launch high-sensitivity assays and expand into emerging markets.

7. Where are the future opportunities in the Aspartate Aminotransferase Test Kit market?

Opportunities include expanding into emerging markets, partnering with telehealth, launching rapid home tests, and leveraging AI to interpret AST levels for holistic liver health.

8. How is technology impacting the Aspartate Aminotransferase Test Kit market?

Advances such as microfluidics, smartphone-linked readers, and lab-on-a-chip cut turnaround to minutes, elevate accuracy, and enable remote monitoring and telehealth integration.

9. How does the regulatory landscape affect the Aspartate Aminotransferase Test Kit market?

FDA approval, CLIA categorization, and the EU’s IVDR 2022 require robust clinical evidence, influencing timelines and costs, but also creating competitive differentiation for compliant kits.

Contact for Full Report

Loading report content...

Aspartate Aminotransferase Test Kit Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

Aspartate Aminotransferase Test Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Aspartate Aminotransferase Test Kit Segmentation

Aspartate Aminotransferase Test Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Aspartate Aminotransferase Test Kit market size?

2. What is the growth forecast for the Aspartate Aminotransferase Test Kit market?

3. What are the key drivers in the Aspartate aminotransferase Test Kit market?

4. What challenges restrain the Aspartase Aminotransferase Test Kit market?

5. Which region dominates the Aspartate Aminotransferase Test Kit market?

6. Who are the top companies in the Aspartate Aminotransferase Test Kit market?

7. Where are the future opportunities in the Aspartate Aminotransferase Test Kit market?

8. How is technology impacting the Aspartate Aminotransferase Test Kit market?

9. How does the regulatory landscape affect the Aspartate Aminotransferase Test Kit market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Aspartate Aminotransferase Test Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Aspartate Aminotransferase Test Kit Segmentation

Aspartate Aminotransferase Test Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Aspartate Aminotransferase Test Kit market size?

2. What is the growth forecast for the Aspartate Aminotransferase Test Kit market?

3. What are the key drivers in the Aspartate aminotransferase Test Kit market?

4. What challenges restrain the Aspartase Aminotransferase Test Kit market?

5. Which region dominates the Aspartate Aminotransferase Test Kit market?

6. Who are the top companies in the Aspartate Aminotransferase Test Kit market?

7. Where are the future opportunities in the Aspartate Aminotransferase Test Kit market?

8. How is technology impacting the Aspartate Aminotransferase Test Kit market?

9. How does the regulatory landscape affect the Aspartate Aminotransferase Test Kit market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation